The Rho kinases I and II regulate different aspects of myosin II activity

Atsuko Yoneda, Hinke A B Multhaupt, John R Couchman, Atsuko Yoneda, Hinke A B Multhaupt, John R Couchman

Abstract

The homologous mammalian rho kinases (ROCK I and II) are assumed to be functionally redundant, based largely on kinase construct overexpression. As downstream effectors of Rho GTPases, their major substrates are myosin light chain and myosin phosphatase. Both kinases are implicated in microfilament bundle assembly and smooth muscle contractility. Here, analysis of fibroblast adhesion to fibronectin revealed that although ROCK II was more abundant, its activity was always lower than ROCK I. Specific reduction of ROCK I by siRNA resulted in loss of stress fibers and focal adhesions, despite persistent ROCK II and guanine triphosphate-bound RhoA. In contrast, the microfilament cytoskeleton was enhanced by ROCK II down-regulation. Phagocytic uptake of fibronectin-coated beads was strongly down-regulated in ROCK II-depleted cells but not those lacking ROCK I. These effects originated in part from distinct lipid-binding preferences of ROCK pleckstrin homology domains. ROCK II bound phosphatidylinositol 3,4,5P(3) and was sensitive to its levels, properties not shared by ROCK I. Therefore, endogenous ROCKs are distinctly regulated and in turn are involved with different myosin compartments.

Figures

Figure 1.
Figure 1.
Activity profiles of ROCK I and II in fibroblast adhesion. (A) Serum-starved REF were plated on FN-coated plates and lysates were prepared at times up to 3 h. GTP-RhoA was pulled down with GST-Rhotekin–immobilized beads. RhoA protein levels in total cell lysate and pull down samples were calculated from Western blots and relative GTP-RhoA levels were normalized to time 0. Error bars show SD. (B) ROCK I and II immunoprecipitates and total cell lysates were subjected to SDS-PAGE and Western blotting with ROCK antibodies. Each antibody is monospecific and only recognizes one ROCK protein. (C) ROCK I and II and actin protein levels in cell lysate from REF plated on FN for the indicated times were analyzed by Western blotting. No changes through cell adhesion were seen. (D) ROCK I and II were specifically immunoprecipitated from lysates at the indicated times in fibroblast adhesion on FN. Kinase activities in immunoprecipitates were analyzed with GST-MLC as substrate. Background radiolabel levels from negative control precipitates were subtracted and the data was normalized to ROCK protein levels in the immunoprecipitates. Error bars show SD.
Figure 2.
Figure 2.
Rho kinase activity in relation to microfilament bundle formation. (A and B) Serum-starved REF were stimulated with 400 ng/ml LPA or control buffer for 5 min and lysed. (A) GTP-RhoA was pulled down from cell lysates and analyzed by Western blotting. One example from duplicate experiments is shown, with increased levels of GTP-RhoA after LPA treatment. (B) Each ROCK was specifically immunoprecipitated, and kinase activities in immunoprecipitates were analyzed as described in Materials and methods. Means of duplicates are shown. Whereas ROCK I activity was enhanced by LPA treatment, that of ROCK II was little changed.
Figure 3.
Figure 3.
ROCK I but not ROCK II activity is essential for focal adhesion and stress fiber formation. (A) Fibroblast cultures were transfected with ROCK I, ROCK II, negative control, or a mixture of ROCK I and II siRNA duplexes. After maintenance culture for 2 d, cells were fixed and stained for paxillin and F-actin. Arrowheads indicate transfected cells. 2 d after transfection with siRNA duplexes, REF were incubated with Y-27632 (10 μM) in the presence of FCS. After 30 min, cells were fixed and stained for F-actin. In all cases, stress fibers were sensitive to Y-27632 addition. (B) Total cell lysates of REF prepared 2 d after transfection with ROCK I (I), ROCK II (II), or control (C) siRNA duplexes were analyzed by Western blotting for ROCK I, ROCK II, and actin. In each case, total populations were analyzed, containing some nontransfected cells. Results from cultures where 80–90% of cells were transfected are shown. (C) REF were cotransfected with myc-tagged full-length human ROCK I or bovine ROCK II cDNA and cy3-labeled ROCK I or II siRNA duplexes. 2 d after transfection, cells were fixed and stained for myc and F-actin. Either ROCK cDNA can restore a normal phenotype. Arrowheads indicate cotransfected cells. Bars, 50 μm.
Figure 4.
Figure 4.
ROCK II–deficient fibroblasts have low phagocytic activity. REF transfected with ROCK I (A), ROCK II (B), and control (C) siRNA were analyzed for phagocytic activity with FN-coated latex red beads as described in Materials and methods. After a 1-h incubation with beads, the cells were fixed and stained for extracellular FN. Three-dimensional fluorescence images of FN (green) and latex beads (red) were recorded from laser scanning confocal microscopy. Intracellular, phagocytosed beads could be seen as red only, whereas beads remaining extracellularly could be detected in both red and green channels. Quantitation is shown in Table I.
Figure 5.
Figure 5.
Endogenous ROCK I and II have distinct distributions. (A) ROCK I in REF cells is largely diffuse in the cytoplasm, more concentrated in perinuclear regions, and sometimes associated with stress fibers (arrowhead). It is not membrane associated unlike ROCK II (B; double arrowheads). ROCK II is also intensely concentrated in perinuclear regions (B, D, and H). After siRNA treatment to deplete ROCK I, its staining is correspondingly reduced (C), whereas that of ROCK II is unaltered (D). Reciprocal results are seen with ROCK II depletion (E and F). Control siRNA treatment was without effect on either rho kinase staining pattern (G and H). Bars, 50 μm.
Figure 6.
Figure 6.
ROCK I– and II–deficient cells contain normal GTPase profiles but are growth retarded. (A) 2 d after siRNA duplex transfection, GTP-RhoA and GTP-Rac1 were analyzed by pull-down assays. Levels are normalized to negative control levels, and error bars indicate SD. In all cases, levels were close to those of control cells. (B) 2 d after transfection with siRNA duplexes, diameters of rounded cells were measured and volumes were calculated as described in Materials and methods. Data were analyzed by one-way ANOVA and showed that cells depleted of ROCK II were significantly larger than control, mock-transfected, or ROCK I–depleted cells (P < 0.001). Double depleted cells were similar to cells depleted of ROCK II alone. (C) At the indicated days after transfection, cell numbers were counted. Error bars show SD. In all cases, control transfections are luciferase DNA target duplexes, whereas mock cultures received oligofectamine only.
Figure 7.
Figure 7.
ROCKs can phosphorylate the same substrates. (A) ROCK I and II immunoprecipitates from REF were incubated with MBP-MYPT1 COOH-terminal fragment and γ-[32P]ATP. Background radiolabel levels from control immunoprecipitates have been deducted. (B) 2 d after transfection with siRNA duplexes, cells were fixed and stained for pMLC2 (Ser19) and F-actin. ROCK I siRNA cells have depleted staining, whereas the abundant stress fibers of ROCK II siRNA stain strongly. Bar, 50 μm. (C and D) Total cell lysates from REF treated with Y-27632 in the presence of serum were analyzed by Western blotting for MLC2 phosphorylation on Ser19 (p-MLC) or Thr18/Ser19 (pp-MLC) (C) and MYPT phosphorylation on Thr853 or Thr696 (D). Although MYPT phosphorylation on Thr853 was reduced, more marked reductions were seen in MLC2 phosphorylation after Rho kinase inhibition. (E and F) Total cell lysates from cells transfected with siRNA duplexes were analyzed by Western blotting for MLC2 phosphorylation on Thr18/Ser19 (E) and MYPT phosphorylation of Thr853 or Thr696 (F). Phosphorylation is normalized to the relevant protein level in the lysates. Phosphorylation levels of MYPT were increased in the absence of ROCK I, partly due to a decrease in myosin phosphatase protein levels in these cells. Error bars show SD.
Figure 8.
Figure 8.
ROCK I and II PH domains do not bind the same PIs. (A) COS7 cells were transfected with ROCK I- or ROCK II-PH-GFP cDNA. After 24 h of transfection, total cell lysates were analyzed by Western blotting with ROCK antibodies. Asterisks show endogenous ROCK proteins and arrowheads indicate ROCK-PH-GFP proteins. (B) Fibroblasts were transfected with ROCK I- or ROCK II-PH-GFP or GRP1-PH-GFP cDNA. 1 d after transfection, cells were fixed and stained for F-actin. In other cases, transfectants were incubated with 30 μM LY294002 for 60 min in the presence of serum and fixed. Arrowheads indicate cell margins with ruffles prominently containing ROCK II and GRP1-PH domains. These structures are absent after PI-3 kinase inhibition. Bar, 50 μm. (C) GST-ROCK I-PH, GST-ROCK II-PH (3.3 nM), and α-actinin (10 nM) were incubated with phospholipid-loaded nitrocellulose membranes. Bound proteins were detected with ROCK or α-actinin antibodies as appropriate. Shown underneath each blot are calibrations where known amounts of each protein were spotted onto nitrocellulose membranes and probed similarly with antibodies. Different binding profiles of ROCK I and II are evident. (D) Recombinant myc-tagged ROCK II was purified from COS-7 cells (high salt method) and the kinase activity was analyzed in the presence of GTPγS GST-RhoA (1 μM), PIs (100 μM), or Y-27632 (1 μM). Error bars show SD.
Figure 9.
Figure 9.
ROCK II activity is regulated by PI-3 kinase. (A) Serum-starved REF were trypsinized and incubated with 10 μM LY294002 or DMSO for 30 min at 37°C. ROCK immunoprecipitates were incubated with MBP-MYPT1 COOH-terminal fragment and γ-[32P]ATP. Background radiolabel levels from control immunoprecipitates have been deducted. ROCK activities from REF treated with DMSO was indicated as one. (B) REF was cotransfected with p110α and pEGFP-N1. 1 d after transfection, cells were fixed and stained for ROCK I or II. Double arrowheads indicate transfected cells and the single arrowhead shows the localization of ROCK II in membrane ruffles. (C) ROCK immunoprecipitates from REF transfected with p110α or control vector were incubated with GST-MLC and γ-[32P]ATP, and the ROCK activities were measured. Activity of mock transfections is indicated as one. Bar, 10 μm.

References

    1. Amano, M., M. Ito, K. Kimura, Y. Fukata, K. Chihara, T. Nakano, Y. Matsuura, and K. Kaibuchi. 1996. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem. 271:20246–20249.
    1. Araki, N., T. Hatae, A. Furukawa, and J.A. Swanson. 2003. Phosphoinositide-3-kinase-independent contractile activities associated with Fcgamma-receptor-mediated phagocytosis and macropinocytosis in macrophages. J. Cell Sci. 116:247–257.
    1. Begum, N., O.A. Sandu, M. Ito, S.M. Lohmann, and A. Smolenski. 2002. Active rho kinase (ROK-α) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells. J. Biol. Chem. 277:6214–6222.
    1. Chen, X.-Q., I. Tan, C.H. Ng, C. Hall, L. Lim, and T. Leung. 2002. Characterization of RhoA-binding kinase ROKα implication of the pleckstrin homology domain in ROKα function using region-specific antibodies. J. Biol. Chem. 277:12680–12688.
    1. Chevrier, V., M. Piel, N. Collomb, Y. Saoudi, R. Frank, M. Paintrand, S. Narumiya, M. Bornens, and D. Job. 2002. The Rho-associated protein kinase p160ROCK is required for centrosome positioning. J. Cell Biol. 157:807–817.
    1. Coleman, M.L., E.A. Sahai, M. Yeo, M. Bosch, A. Dewar, and M.F. Olson. 2001. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3:339–345.
    1. Couchman, J.R., S. Vogt, S.T. Lim, Y. Lim, E.S. Oh, G.D. Prestwich, A. Theibert, W. Lee, and A. Woods. 2002. Regulation of inositol phospholipid binding and signalling through syndecan-4. J. Biol. Chem. 277:49296–49303.
    1. Cox, D., J.S. Berg, M. Cammer, J.O. Chinegwundoh, B.M. Dale, R.E. Cheney, and S. Greenberg. 2002. Myosin X is a downstream effector of PI(3)K during phagocytosis. Nat. Cell Biol. 4:469–477.
    1. Davies, S.P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95–105.
    1. Dowler, S., G. Kular, and D.R. Alessi. 2002. Protein lipid overlay assay. Sci. STKE. 2002:PL6.
    1. Dvorsky, R., L. Blumenstein, I.R. Vetter, and M.R. Ahmadian. 2004. Structural insights into the interaction of ROCKI with the switch regions of RhoA. J. Biol. Chem. 279:7098–7104.
    1. Edwards, D.C., L.C. Sanders, G.M. Bokoch, and G.N. Gill. 1999. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat. Cell Biol. 1:253–259.
    1. Etienne-Manneville, S., and A. Hall. 2002. Rho GTPases in cell biology. Nature. 420:629–635.
    1. Feng, J., M. Ito, Y. Kureishi, K. Ichikawa, M. Amano, N. Isaka, K. Okawa, A. Iwamatsu, K. Kaibuchi, D.J. Hartshorne, and T. Nakano. 1999. Rho-associated kinase of chicken gizzard smooth muscle. J. Biol. Chem. 274:3744–3752.
    1. Fraley, T.S., T.C. Tran, A.M. Corgan, C.A. Nash, J. Hao, D.R. Critchley, and J.A. Greenwood. 2003. Phosphoinositide binding inhibits α-actinin bundling activity. J. Biol. Chem. 278:24039–24045.
    1. Gray, A., J. Van der Kaay, and C.P. Downes. 1999. The pleckstrin homology domains of protein kinase B and GRP1 (general receptor for phosphoinositides-1) are sensitive and selective probes for the cellular detection of phosphatidylinositol 3,4-bisphosphate and/or phosphatidylinositol 3,4,5-trisphosphate in vivo. Biochem. J. 344:929–936.
    1. Hartshorne, D.J., M. Ito, and F. Erdodi. 2004. Role of protein phosphatase type 1 in contractile functions: myosin phosphatase. J. Biol. Chem. 279:37211–37214.
    1. Insall, R.H., and O.D. Weiner. 2001. PIP3, PIP2, and cell movement—similar messages, different meanings? Dev. Cell. 1:743–747.
    1. Kawabata, S., J. Usukura, N. Morone, M. Ito, A. Iwamatsu, K. Kaibuchi, and M. Amano. 2004. Interaction of Rho-kinase with myosin II at stress fibres. Genes Cells. 9:653–660.
    1. Kawano, Y., Y. Fukata, N. Oshiro, M. Amano, T. Nakamura, M. Ito, F. Matsumura, M. Inagaki, and K. Kaibuchi. 1999. Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by rho-kinase in vivo. J. Cell Biol. 147:1023–1038.
    1. Kureishi, Y., S. Kobayashi, M. Amano, K. Kimura, H. Kanaide, T. Nakano, K. Kaibuchi, and M. Ito. 1997. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J. Biol. Chem. 272:12257–12260.
    1. Leung, T., X.Q. Chen, E. Manser, and L. Lim. 1996. The p160 RhoA-binding kinase ROKα is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol. Cell. Biol. 16:5313–5327.
    1. Limouze, J., A.F. Straight, T. Mitchison, and J.R. Sellers. 2004. Specificity of blebbistatin, an inhibitor of myosin II. J. Muscle Res. Cell Motil. 25:337–341.
    1. Maekawa, M., T. Ishizaki, S. Boku, N. Watanabe, A. Fujita, A. Iwamatsu, T. Obinata, K. Ohashi, K. Mizuno, and S. Narumiya. 1999. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science. 285:895–898.
    1. Nakagawa, O., K. Fujisawa, T. Ishizaki, Y. Saito, K. Nakao, and S. Narumiya. 1996. ROCK-I and ROCK-II, two isoforms of rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett. 392:189–193.
    1. Narumiya, S., T. Ishizaki, and M. Uehata. 2000. Use and properties of ROCK-specific inhibitor Y-27632. Methods Enzymol. 325:273–284.
    1. Olazabal, I.M., E. Caron, R.C. May, K. Schilling, D.A. Knecht, and L.M. Machesky. 2002. Rho-kinase and myosin-II control phagocytic cup formation during CR, but not FcgammaR, phagocytosis. Curr. Biol. 12:1413–1418.
    1. Ren, X.D., W.B. Kiosses, and M.A. Schwartz. 1999. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18:578–585.
    1. Ridley, A.J., and A. Hall. 1992. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 70:389–399.
    1. Riento, K., and A.J. Ridley. 2003. Rocks: multifunctional kinases in cell behaviour. Nat. Rev. Mol. Cell Biol. 4:446–456.
    1. Riento, K., R.M. Guasch, R. Garg, B. Jin, and A.J. Ridley. 2003. RhoE binds to ROCK I and inhibits downstream signaling. Mol. Cell. Biol. 23:4219–4229.
    1. Riento, K., N. Totty, P. Villalonga, R. Garg, R. Guasch, and A.J. Ridley. 2005. RhoE function is regulated by ROCK I-mediated phosphorylation. EMBO J. 24:1170–1180.
    1. Sebbagh, M., C. Renvoizé, J. Hamelin, N. Riché, J. Bertoglio, and J. Bréard. 2001. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat. Cell Biol. 3:346–352.
    1. Shimizu, T., K. Ihara, R. Maesaki, M. Amano, K. Kaibuchi, and T. Hakoshima. 2003. Parallel coiled-coil association of the rhoA-binding domain in Rho-kinase. J. Biol. Chem. 278:46046–46051.
    1. Shimizu, Y., D. Thumkeo, J. Keel, T. Ishizaki, H. Oshima, M. Oshima, Y. Noda, F. Matsumura, M.M. Taketo, and S. Narumiya. 2005. ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles. J. Cell Biol. 168:941–953.
    1. Sin, W.-C., X.-Q. Chen, T. Leung, and L. Lim. 1998. RhoA-binding kinase α translocation is facilitated by the collapse of the vimentin intermediate filament network. Mol. Cell. Biol. 18:6325–6339.
    1. Sordella, R., M. Classon, K.Q. Hu, S.F. Matheson, M.R. Brouns, B. Fine, L. Zhang, H. Takami, Y. Yamada, and J. Settleman. 2002. Modulation of CREB activity by the rho GTPase regulates cell and organism size during mouse embryonic development. Dev. Cell. 2:553–565.
    1. Sumi, T., K. Matsumoto, and T. Nakamura. 2001. a. Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase. J. Biol. Chem. 276:670–676.
    1. Sumi, T., K. Matsumoto, A. Shibuya, and T. Nakamura. 2001. b. Activation of LIM kinases by myotonic dystrophy kinase-related Cdc42-binding kinase alpha. J. Biol. Chem. 276:23092–23096.
    1. Swanson, J.A., and A.D. Hoppe. 2004. The coordination of signalling during Fc receptor-mediated phagocytosis. J. Leukoc. Biol. 76:1093–1103.
    1. Tall, E.G., I. Spector, S.N. Pentyala, I. Bitter, and M.J. Rebecchi. 2000. Dynamics of phosphatidylinositol 4,5-bisphosphate in actin-rich structures. Curr. Biol. 10:743–746.
    1. Thumkeo, D., J. Keel, T. Ishizaki, M. Hirose, K. Nonomura, H. Oshima, M. Oshima, M.M. Taketo, and S. Narumiya. 2003. Targeted disruption of the mouse rho-associated kinase 2 gene results in intrauterine growth retardation and fetal death. Mol. Cell. Biol. 23:5043–5055.
    1. Velasco, G., C. Armstrong, N. Morrice, S. Frame, and P. Cohen. 2002. Phosphorylation of the regulatory subunit of smooth muscle protein phosphatase 1M at Thr 850 induces its dissociation from myosin. FEBS Lett. 527:101–104.
    1. Vlahos, C.J., W.F. Matter, K.Y. Hui, and R.F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241–5248.
    1. Wilkinson, S., H.F. Paterson, and C.J. Marshall. 2005. Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion. Nat. Cell Biol. 7:255–261.

Source: PubMed

3
Abonneren